SAN DIEGO--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced it has received FDA 510(k) clearance for its next-generation vMap ® ...

With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...

Vektor Medical Receives FDA 510(k) Clearance Adding Atrial Flutter Mapping, Enhanced Connectivity and New Integration Capabilities to Next-Generation vMap Clearance Expands vMap’s Non-Invasive Mapping ...

The MarketWatch News Department was not involved in the creation of this content. Clearance Expands vMap's Non-Invasive Mapping Capabilities with Direct ECG Data Streaming, Software-Only Deployment ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced it has received FDA 510(k) clearance for its next-generation vMap ® technology. The clearance expands ...

Vektor Medical, a medical technology company headquartered in San Diego redefining how arrhythmias are understood and treated, announced it has received the US Food and Drug Administration 510(k) ...

Atrial flutter is an abnormal heart rhythm where the upper heart chambers beat too fast, reducing the heart’s ability to pump blood effectively and potentially leading to heart muscle damage, stroke, ...